157 related articles for article (PubMed ID: 11376700)
1. Involvement of gap junctions in tumor suppression: analysis of genetically-manipulated mice.
Omori Y; Zaidan Dagli ML; Yamakage K; Yamasaki H
Mutat Res; 2001 Jun; 477(1-2):191-6. PubMed ID: 11376700
[TBL] [Abstract][Full Text] [Related]
2. Role of connexin (gap junction) genes in cell growth control and carcinogenesis.
Yamasaki H; Krutovskikh V; Mesnil M; Tanaka T; Zaidan-Dagli ML; Omori Y
C R Acad Sci III; 1999; 322(2-3):151-9. PubMed ID: 10196667
[TBL] [Abstract][Full Text] [Related]
3. Delayed liver regeneration and increased susceptibility to chemical hepatocarcinogenesis in transgenic mice expressing a dominant-negative mutant of connexin32 only in the liver.
Dagli ML; Yamasaki H; Krutovskikh V; Omori Y
Carcinogenesis; 2004 Apr; 25(4):483-92. PubMed ID: 14688024
[TBL] [Abstract][Full Text] [Related]
4. Ablation of gap junctional communication in hepatocytes of transgenic mice does not lead to disrupted cellular homeostasis or increased spontaneous tumourigenesis.
Ott T; Jokwitz M; Lenhard D; Romualdi A; Dombrowski F; Ittrich C; Schwarz M; Willecke K
Eur J Cell Biol; 2006 Aug; 85(8):717-28. PubMed ID: 16740338
[TBL] [Abstract][Full Text] [Related]
5. Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation.
King TJ; Lampe PD
Carcinogenesis; 2004 May; 25(5):669-80. PubMed ID: 14742325
[TBL] [Abstract][Full Text] [Related]
6. Neoplastic phenotype of gap-junctional intercellular communication-deficient WB rat liver epithelial cells and its reversal by forced expression of connexin 32.
Rae RS; Mehta PP; Chang CC; Trosko JE; Ruch RJ
Mol Carcinog; 1998 Jun; 22(2):120-7. PubMed ID: 9655256
[TBL] [Abstract][Full Text] [Related]
7. Role of connexin (gap junction) genes in cell growth control: approach with site-directed mutagenesis and dominant-negative effects.
Omori Y; Duflot-Dancer A; Mesnil M; Yamasaki H
Toxicol Lett; 1998 Aug; 96-97():105-10. PubMed ID: 9820654
[TBL] [Abstract][Full Text] [Related]
8. High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32.
Temme A; Buchmann A; Gabriel HD; Nelles E; Schwarz M; Willecke K
Curr Biol; 1997 Sep; 7(9):713-6. PubMed ID: 9285723
[TBL] [Abstract][Full Text] [Related]
9. Genetic and epigenetic changes of intercellular communication genes during multistage carcinogenesis.
Yamasaki H; Omori Y; Zaidan-Dagli ML; Mironov N; Mesnil M; Krutovskikh V
Cancer Detect Prev; 1999; 23(4):273-9. PubMed ID: 10403898
[TBL] [Abstract][Full Text] [Related]
10. Transgenic disruption of gap junctional intercellular communication enhances early but not late stage hepatocarcinogenesis in the rat.
Hokaiwado N; Asamoto M; Ogawa K; Shirai T
Toxicol Pathol; 2005; 33(6):695-701. PubMed ID: 16243774
[TBL] [Abstract][Full Text] [Related]
11. Connexin 32 fused to the green fluorescent protein retains its ability to control the proliferation of thyroid cells.
Flachon V; Durand C; Selmi-Ruby S; Rousset B; Munari-Silem Y
Cell Commun Adhes; 2001; 8(4-6):447-52. PubMed ID: 12064633
[TBL] [Abstract][Full Text] [Related]
12. Gap junction proteins connexin32 and connexin43 partially acquire growth-suppressive function in HeLa cells by deletion of their C-terminal tails.
Omori Y; Yamasaki H
Carcinogenesis; 1999 Oct; 20(10):1913-8. PubMed ID: 10506104
[TBL] [Abstract][Full Text] [Related]
13. Connexin 32 gap junctions enhance stimulation of glucose output by glucagon and noradrenaline in mouse liver.
Stümpel F; Ott T; Willecke K; Jungermann K
Hepatology; 1998 Dec; 28(6):1616-20. PubMed ID: 9828226
[TBL] [Abstract][Full Text] [Related]
14. The gap junction protein connexin32 is a mouse lung tumor suppressor.
King TJ; Lampe PD
Cancer Res; 2004 Oct; 64(20):7191-6. PubMed ID: 15492231
[TBL] [Abstract][Full Text] [Related]
15. Connexin 32 dominant-negative mutant transgenic rats are resistant to hepatic damage by chemicals.
Asamoto M; Hokaiwado N; Murasaki T; Shirai T
Hepatology; 2004 Jul; 40(1):205-10. PubMed ID: 15239104
[TBL] [Abstract][Full Text] [Related]
16. Connexin 32 mutations from X-linked Charcot-Marie-Tooth disease patients: functional defects and dominant negative effects.
Omori Y; Mesnil M; Yamasaki H
Mol Biol Cell; 1996 Jun; 7(6):907-16. PubMed ID: 8816997
[TBL] [Abstract][Full Text] [Related]
17. Both early and late stages of hepatocarcinogenesis are enhanced in Cx32 dominant negative mutant transgenic rats with disrupted gap junctional intercellular communication.
Hokaiwado N; Asamoto M; Futakuchi M; Ogawa K; Takahashi S; Shirai T
J Membr Biol; 2007 Aug; 218(1-3):101-6. PubMed ID: 17978847
[TBL] [Abstract][Full Text] [Related]
18. Cx32 formation and/or Cx32-mediated intercellular communication induces expression and function of tight junctions in hepatocytic cell line.
Kojima T; Spray DC; Kokai Y; Chiba H; Mochizuki Y; Sawada N
Exp Cell Res; 2002 May; 276(1):40-51. PubMed ID: 11978007
[TBL] [Abstract][Full Text] [Related]
19. Endotoxin unmasks the role of gap junctions in the liver.
Correa PR; Guerra MT; Leite MF; Spray DC; Nathanson MH
Biochem Biophys Res Commun; 2004 Sep; 322(3):718-26. PubMed ID: 15336523
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibition in G(1) and altered expression of cyclin D1 and p27(kip-1 )after forced connexin expression in lung and liver carcinoma cells.
Koffler L; Roshong S; Kyu Park I; Cesen-Cummings K; Thompson DC; Dwyer-Nield LD; Rice P; Mamay C; Malkinson AM; Ruch RJ
J Cell Biochem; 2000 Sep; 79(3):347-54. PubMed ID: 10972973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
